Efficacy of serum chitotriosidase activity in early treatment of patients with active tuberculosis and a negative sputum smear

Therapeutics and Clinical Risk Management

Volumn 8, Issue , 2012, Pages 369-372

  Tasci, Canturk ^a   Tapan, Serkan ^a   Ozkaya, Sevket ^b   Demirer, Ersin ^a   Deniz, Omer ^a   Balkan, Arzu ^a   Ozkan, Metin ^a   Inan, Ilker ^a   Kurt, Ismail ^a   Bilgic, Hayati ^a  

^a Department of Pulmonary Diseases ^*  (Turkey)

^b Dr Suat Seren Education and Research Hospital for Chest Diseases and Thoracic Surgery   (Turkey)

Author keywords

Antituberculous treatment; Diagnosis; Disease activity; Pulmonary tuberculosis; Serum chitotriosidase

Indexed keywords

CHITOTRIOSIDASE;

ACID FAST BACTERIUM; ADULT; ARTICLE; BACTERIUM CULTURE; BLOOD CELL COUNT; CONTROLLED STUDY; DRUG EFFICACY; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LABORATORY TEST; LUNG TUBERCULOSIS; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS;

EID: 84875349260     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S31752     Document Type: Article

References (12)

1. American Thoracic Society and Centers for Diseases Control and Prevention. Treatment of tuberculosis infection in adults and children. Am Rev Respir Dis. 1994;263:1359-1374.
2. Chan ED, Heifets L, Iseman MD. Immunologic diagnosis of tuberculosis: a review. Tuber Lung Dis. 2000;80:131-140.
3. Al Zahrani K, Jahdali H, Poirier P, et al. Accuracy and utility of commercially available amplification and serologic tests for the diagnosis of minimal pulmonary tuberculosis. Am J Respir Crit Care Med. 2000;162:1323-1329.
4. Khomenko A, Bayensky A, Chernousova L, et al. Serodiagnosis of tuberculosis: detection of mycobacterial antibodies and antigens. Tuber Lung Dis. 1996;77:510-515.
5. Renkema GH, Boot RG, Strijland A, et al. Synthesis, sorting, and processing into distinct isoforms of human macrophage chitotriosidase. Eur J Biochem. 1997;244:279-285.
6. Kanaya AM, Glidden DV, Chambers HF. Identifying pulmonary tuberculosis in patients with negative sputum smear results. Chest. 2001;120: 349-355.
7. Guo Y, He W, Boer AM, et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis. 1995;18: 717-722.
8. Casal JA, Lacerda L, Pérez LF, et al. Relationship between serum markers of monocyte/macrophage activation in type 1 Gaucher's disease. Clin Chem Lab Med. 2002;40:52-55.
9. Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest. 1994;93:1288-1292.
10. Canudas J, Cenarro A, Civeira F, et al. Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipid-lowering agents, atorvastatin and bezafibrate. Metabolism. 2001; 50:447-450.
11. Wajner A, Michelin K, Burin MG, et al. Biochemical characterisation of chitotriosidase enzyme. Comparison between normal individuals and patients with Gaucher and Niemann-Pick disease. Clin Biochem. 2004;37:893-897.
12. Bargagli E, Margollicci M, Nikiforakis N, et al. Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis. Respiration. 2007;74:548-552.